BioAge Labs, Inc • BIOA

Capital at risk.

About BioAge Labs, Inc
Ticker
info
BIOA
Trading on
info
NASDAQ
ISIN
info
-
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Dr. Kristen Fortney Ph.D.
Headquarters
info
1445A South 50th Street, Richmond, CA, United States, 94804
Employees
info
62
Website
info
https://bioagelabs.com
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
Metrics
BasicAdvanced
Market cap
info
$674M
P/E ratio
info
-
EPS
info
-$5.40
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
$-51.4M
Ex dividend date
info
-
Price & volume
Market cap
info
$674M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0
Earnings
EPS
info
-$5.40
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-51.4M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-
52-week High
info
$26.62
52-week Low
info
$3.85
50-day moving average
info
$20.02
200-day moving average
info
$20.02
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
0.00%
ROA (TTM)
info
0.00%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
34.2M
Float
info
1.2M
Insiders %
info
3.80%
Institutions %
info
32.64%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.68
-
-
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-23.4M
∞%
Q3 • 24
$0M
$-21.1M
∞%
Q4 • 24
NaN%
9.73%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$337M
$23.6M
7.00%
Q3 • 24
$358M
$35.1M
9.80%
Q4 • 24
6.18%
48.55%
39.90%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-14.9M
$-0.3M
$191M
$-15.2M
Q3 • 24
$-5.1M
$-0M
$24.9M
$-5.2M
Q4 • 24
65.59%
91.48%
86.94%
66.11%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a BioAge Labs, Inc share?
Collapse

BioAge Labs, Inc shares are currently traded for undefined per share.

How many shares does BioAge Labs, Inc have?
Collapse

BioAge Labs, Inc currently has 34.2M shares.

Does BioAge Labs, Inc pay dividends?
Collapse

No, BioAge Labs, Inc doesn't pay dividends.

What is BioAge Labs, Inc 52 week high?
Collapse

BioAge Labs, Inc 52 week high is $26.62.

What is BioAge Labs, Inc 52 week low?
Collapse

BioAge Labs, Inc 52 week low is $3.85.

What is the 200-day moving average of BioAge Labs, Inc?
Collapse

BioAge Labs, Inc 200-day moving average is $20.02.

Who is BioAge Labs, Inc CEO?
Collapse

The CEO of BioAge Labs, Inc is Dr. Kristen Fortney Ph.D..

How many employees BioAge Labs, Inc has?
Collapse

BioAge Labs, Inc has 62 employees.

What is the market cap of BioAge Labs, Inc?
Collapse

The market cap of BioAge Labs, Inc is $674M.

What is the P/E of BioAge Labs, Inc?
Collapse

The current P/E of BioAge Labs, Inc is null.

What is the EPS of BioAge Labs, Inc?
Collapse

The EPS of BioAge Labs, Inc is -$5.40.

What is the PEG Ratio of BioAge Labs, Inc?
Collapse

The PEG Ratio of BioAge Labs, Inc is null.